マルチレベルの健康関連の社会的ニーズイニシアチブの有効性の評価
The goal of this study is to evaluate the effectiveness of a multi-level health-related social needs (HRSN) initiative among adult patients diagnosed with type 2 diabetes, plus hypertension or hyperlipidemia. The multi-level initiative includes HRSN data collection, training and tools for health care professionals, care coordinator support, and community resources. Patients with type 2 diabetes plus hypertension or hyperlipidemia will be screened for HRSN as part of the primary care clinic intake process to assess if patients have any social needs (like difficulty with getting food, housing, or transportation). If patients screen positive for having social needs, then patients will be offered support, which can include help from primary care providers with adjusting a patient's disease management plan, referrals to care coordinators to provide additional assistance in addressing social needs, and information about community organizations that offer resources for social needs. The initiative will be integrated as a system change across VUMC adult primary care practices.
The investigators will use a prospective, single-arm clinical trial to evaluate effects on clinical outcomes for 12 months. Data will be extracted from the EHR on adult patients diagnosed with type 2 diabetes, and either hypertension or hyperlipidemia. The investigators hypothesize that the initiative will reduce the impact of HRSN on clinical outcomes over the study period. The investigators will also administer surveys to a subgroup of patients to examine trends in self-reported psychosocial and behavioral measures over the course of the initiative.
調査の概要
研究の種類
入学 (実際)
段階
- 適用できない
連絡先と場所
研究場所
-
-
Tennessee
-
Nashville、Tennessee、アメリカ、37203
- Vanderbilt University Medical Center
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
ELIGIBILITY CRITERIA FOR EHR DATA EXTRACTION
Inclusion Criteria:
- 18 years of age or older
- Completed the health-related social needs (HRSN) screener as part of a primary care visit
- Diagnosed with type 2 diabetes, plus hypertension and/or hyperlipidemia as reflected by ICD-10 billing codes
- Receive care at one of six partner Vanderbilt University Medical Center primary care clinics: South One Hundred Oaks, North One Hundred Oaks, Green Hills, Hillsboro Medical Group, Melrose, Bellevue
ELIGIBILITY CRITERIA FOR PATIENT SURVEYS (subset of EHR data)
Inclusion Criteria:
- 18 years of age or older
- Completed the HRSN screener as part of a primary care visit
- Diagnosed with type 2 diabetes
- Receive care at one of six partner Vanderbilt University Medical Center primary care clinics: South One Hundred Oaks, North One Hundred Oaks, Green Hills, Hillsboro Medical Group, Melrose, Bellevue
- English-speaking
Exclusion Criteria:
- Blindness
- Hearing impairment
- Conditions that would interfere with survey completion (e.g., significant dementia, active psychosis or mania)
- Being near the end of life (hospice or home hospice)
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:ヘルスサービス研究
- 割り当て:なし
- 介入モデル:単一グループの割り当て
- マスキング:なし(オープンラベル)
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
実験的:Multi-level HRSN initiative
Eligible patients will receive the HRSN initiative as part of their primary care appointments |
The multi-level health-related social needs (HRSN) initiative includes multiple components aimed at assessing and addressing HRSN in clinical practice: HRSN screening, EHR tools for clinical decision support, training and tools for health care providers to address HRSN, care coordinator support for patient outreach, and community resources for referral and support. |
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Change in glycemic control
時間枠:Baseline and 12 months post-baseline
|
Hemoglobin A1c extracted from the electronic health record where higher values indicate worse glycemic control. |
Baseline and 12 months post-baseline
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Change in cholesterol
時間枠:Baseline and 12 months post-baseline
|
Low-density lipoprotein (LDL) extracted from the electronic health record where higher values indicate worse hyperlipidemia. |
Baseline and 12 months post-baseline
|
|
Change in blood pressure
時間枠:Baseline and 12 months post-baseline
|
Systolic blood pressure extracted from the EHR where higher values indicate worse hypertension. |
Baseline and 12 months post-baseline
|
その他の成果指標
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Change in medication adherence (survey)
時間枠:Baseline and 6 months post-baseline
|
As assessed by the Adherence to Refills and Medications Scale-Diabetes (ARMS-D) with scores ranging from 11-44, where higher scores indicate more problems with medication adherence (worse). |
Baseline and 6 months post-baseline
|
|
Change in dietary behavior (survey)
時間枠:Baseline and 6 months post-baseline
|
As assessed by the short version of the Personal Diabetes Questionnaire scale (PDQ-11) Eating Behavior Problems subscale with scores ranging 1-6, where higher scores indicate more problem eating behaviors (worse). |
Baseline and 6 months post-baseline
|
|
Change in dietary behavior (survey)
時間枠:Baseline and 6 months post-baseline
|
As assessed by the short version of the Personal Diabetes Questionnaire scale (PDQ-11) Use of Information for Decision Making subscale with scores ranging 1-6, where higher scores indicate more use of dietary information for decision making (better). |
Baseline and 6 months post-baseline
|
|
Change in physical activity (survey)
時間枠:Baseline and 6 months post-baseline
|
As assessed by scores on the Exercise Vital Sign (EVS) Tool with scores ranging 0-1,050 minutes or greater per week of moderate to strenuous physical activity. |
Baseline and 6 months post-baseline
|
|
Change in diabetes distress (survey)
時間枠:Baseline and 6 months post-baseline
|
As assessed by the Problem Areas in Diabetes-5 (PAID-5) scale with scores ranging from 0 to 20, where higher scores indicate greater diabetes-related emotional distress (worse). |
Baseline and 6 months post-baseline
|
|
Change in diabetes self-efficacy (survey)
時間枠:Baseline and 6 months post-baseline
|
As assessed by the Perceived Diabetes Self-Management Scale (PDSMS) with scores ranging 8 to 40, where higher scores indicate more self-efficacy (better). |
Baseline and 6 months post-baseline
|
|
Change in interpersonal processes of care (survey)
時間枠:Baseline and 6 months post-baseline
|
As assessed by the Interpersonal Processes of Care (IPC) survey with scores ranging from 1-5 (calculated as the mean of non-missing responses to the corresponding items), where higher scores indicate higher frequency of the labeled interpersonal process (e.g., decided together; lack of clarity). Scoring occurs for 7 interpersonal processes: lack of clarity; elicited concerns, responded; explained results; decided together; emotional support, compassion; discriminated due to race/ethnicity; and disrespectful office staff. |
Baseline and 6 months post-baseline
|
|
Change in perceived discrimination (survey)
時間枠:Baseline and 6 months post-baseline
|
As assessed on the Discrimination in Medical Settings scale with scores ranging from 7-35, where higher scores indicate higher frequency of experiences with discrimination in medical settings. |
Baseline and 6 months post-baseline
|
協力者と研究者
捜査官
- 主任研究者:Sunil Kripalani, MD, MSc、Vanderbilt University Medical Center
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (実際)
研究の完了 (実際)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
その他の研究ID番号
- 241778
- P50MD017347-03S3 (米国 NIH グラント/契約)
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
IPD プランの説明
After study results are posted on clinical trials and published, de-identified data will be available upon requests made to the principal investigator.
IPD 共有時間枠
After study results are posted on clinical trials and outcomes published in a peer-reviewed journal, until 5 years later
IPD 共有アクセス基準
Contact the principal investigator
IPD 共有サポート情報タイプ
- STUDY_PROTOCOL
- SAP
- ICF
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。